Business
Wedge Industrial: Revenue and profit surged, with robust growth in pharma and alloy businesses and strategic investments
Wedge Industrial: Revenue and profit surged, with robust growth in pharma and alloy businesses and strategic investments

About this update from Wedge Industrial Co., Ltd. Class A
Revenue and net profit grew 24.40% and 21.84% year-over-year, driven by strong performance in both pharmaceutical and high-temperature alloy segments. The company advanced R&D, completed a major share buyback, and established a ¥1 billion M&A fund.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
View stock analysis, news, and events for Wedge Industrial Co., Ltd. Class A